What is the difference between Saxenda, Rybelsus, and Wegovy?

Saxenda (liraglutide), Rybelsus (semaglutide), and Wegovy (semaglutide) are GLP-1 medications used for weight management or type 2 diabetes. Key differences: Saxenda is FDA-approved, Rybelsus is FDA-approved, Wegovy is FDA-approved.

Which is most effective for weight loss: Saxenda, Rybelsus, or Wegovy?

Effectiveness varies by individual. In clinical trials, tirzepatide-based drugs (Mounjaro, Zepbound) produced ~22% average body-weight loss vs ~15% for semaglutide-based (Ozempic, Wegovy). Discuss with your prescriber.

Cash retail price: Rybelsus $968/mo · Saxenda $1349/mo · Wegovy $1349/mo. Compounded versions through telehealth typically run 60-80% less.

3-way comparison

Saxenda vs Rybelsus vs Wegovy

Side-by-side breakdown — efficacy, cost, regulatory status, and who each option fits best.

Saxenda

liraglutide

Rybelsus

semaglutide

Wegovy

semaglutide

Side-by-side comparison

Attribute	Saxenda	Rybelsus	Wegovy
Generic name	liraglutide	semaglutide	semaglutide
Drug class	—	—	—
Regulatory status	FDA approved	FDA approved	FDA approved
Manufacturer	Novo Nordisk	Novo Nordisk	Novo Nordisk
Avg retail price	$1349/mo	$968/mo	$1349/mo
Without insurance	$1100–$1500/mo	$850–$1100/mo	$1349–$1500/mo
Savings card max	$25/mo	$10/mo	$0/mo
Shortage status

Saxenda vs Rybelsus vs Wegovy

Side-by-side comparison

FAQ

2-way head-to-heads

Already on one? Switching guides

None feel right? See alternatives